ClinicalTrials.gg
Drug

AMG 757 clinical trials

Also written Tarlatamab, AMG 757 and Imdelltra.

studies test it
30
open now
19
in phase 3
7
first study started
2017

How each study uses AMG 757 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the AMG 757 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 May 2024 · IMDELLTRA · BLA 761344 (FDA, Drugs@FDA)
European Union
29 May 2026 · Imdylltra · EMEA/H/C/006451 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Brand

Imdelltra
8

Development codes

AMG 757
11

Other names

Tarlatamab
29

Studies by the year they started

28 studies that test it; most in 2025 (11); 2 more planned to start later

Studies that test AMG 757, by start year
YearStudies
20171
20212
20231
20244
202511
20269

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
17
Phase 3
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 17

Amgen (13) · Vall d'Hebron Institute of Oncology (1) · PrECOG, LLC. (1) · Maastricht University Medical Center (1) · AIO-Studien-gGmbH (1) · University of Arizona (1) · ETOP IBCSG Partners Foundation (1) · National Taiwan University Hospital (1)

Often tested with

Tested in the same studies.

Tambotatug pelitecan (1) · Temozolomide (1) · Etoposide (1) · Carboplatin (1) · Zocilurtatug Pelitecan (1) · Sacituzumab govitecan (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 1 in phase 3

Studies that test AMG 757, phase 3 first.

Studies

Open first, then newest update. How each study uses AMG 757 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 30

See all 30 studies that test AMG 757 →

Given beside what is tested · 6 — AMG 757 is usual care or a partner of the new treatment

Codes

What other systems call AMG 757 · ClinicalTrials.gg INT001867

  • MeSH (NLM) C000722655AMG 757Confirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 74X82ST8Q1TARLATAMABConfirmed FDA, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.